Papers

1

Total Citations

4

H-Index

1

About

Laurent Debarbieux is a leading figure in bacteriophage research, focusing on the development of phages as precision therapeutics against multidrug-resistant bacterial infections. His work bridges fundamental microbiology and clinical application, with a major contribution being the validation of high-throughput methods for phage potency testing—a critical step demanded by regulatory agencies as phage banks expand. His 2024 study on automated pipetting and phage drop-off methods, already garnering 4 citations, exemplifies his drive to standardize phage quality control, ensuring reliable and reproducible treatments for patients. Beyond this, Debarbieux has pioneered the use of animal models to study phage-bacteria dynamics in vivo, advancing our understanding of how phages can be deployed effectively against infections like Pseudomonas aeruginosa. His research has been instrumental in shaping the regulatory landscape for phage therapy, earning recognition from both scientific and medical communities. With a career spanning over two decades, Debarbieux’s work has directly influenced the transition of phages from experimental tools to viable pharmaceutical ingredients, making him a key architect in the renaissance of phage therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Bacteriophage Testing with Potency Determination: Validation of an Automated Pipetting and Phage Drop-Off Method
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Centre National de la Recherche Scientifique

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 0 days ago